6.72
price up icon1.95%   0.14
 
loading

89 Bio Inc Borsa (ETNB) Ultime notizie

pulisher
04:27 AM

89bio (NASDAQ:ETNB) Given Buy Rating at HC Wainwright - Defense World

04:27 AM
pulisher
Jan 21, 2025

89bio shares maintain Buy rating as analyst cites confidence in pegozafermin trial outcomes - MSN

Jan 21, 2025
pulisher
Jan 21, 2025

HC Wainwright Reiterates Buy Rating for 89bio (NASDAQ:ETNB) - MarketBeat

Jan 21, 2025
pulisher
Jan 20, 2025

Weiss Ratings Reiterates Sell (D-) Rating for 89bio (NASDAQ:ETNB) - MarketBeat

Jan 20, 2025
pulisher
Jan 20, 2025

Hennion & Walsh Asset Management Inc. Takes $739,000 Position in 89bio, Inc. (NASDAQ:ETNB) - MarketBeat

Jan 20, 2025
pulisher
Jan 20, 2025

89bio (NASDAQ: ETNB) Provides Corporate Update and Business Outlook for 2025SAN FRANCISCO, January 13, 2025 (GLOBE NEWSWIRE) – 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company specializing in innovative therapies for l - Defense World

Jan 20, 2025
pulisher
Jan 20, 2025

Weiss Ratings Reiterates “Sell (D-)” Rating for 89bio (NASDAQ:ETNB) - Defense World

Jan 20, 2025
pulisher
Jan 19, 2025

89bio, Inc. (NASDAQ:ETNB) Short Interest Up 12.2% in December - MarketBeat

Jan 19, 2025
pulisher
Jan 19, 2025

89bio (NASDAQ:ETNB) Hits New 12-Month Low After Insider Selling - Defense World

Jan 19, 2025
pulisher
Jan 18, 2025

89bio, Inc. (NASDAQ:ETNB) Insider Sells $71,149.87 in Stock - MarketBeat

Jan 18, 2025
pulisher
Jan 17, 2025

89bio's chief technical operations officer sells $71,149 in stock - MSN

Jan 17, 2025
pulisher
Jan 17, 2025

89bio's chief technical operations officer sells $71,149 in stock By Investing.com - Investing.com South Africa

Jan 17, 2025
pulisher
Jan 17, 2025

89bio (NASDAQ:ETNB) Stock Price Down 4%Time to Sell? - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

89bio (NASDAQ:ETNB) Reaches New 12-Month LowTime to Sell? - MarketBeat

Jan 17, 2025
pulisher
Jan 13, 2025

89bio: Advancement Of Pegozafermin For SHTG Is Another Path Forward (NASDAQ:ETNB) - Seeking Alpha

Jan 13, 2025
pulisher
Jan 13, 2025

89bio Provides Business Update and Outlook for 2025 - The Manila Times

Jan 13, 2025
pulisher
Jan 13, 2025

89bio Completes Phase 3 Trial Enrollment, Fortifies Position with $440M Cash Reserve - StockTitan

Jan 13, 2025
pulisher
Jan 13, 2025

89bio (NASDAQ:ETNB) Sets New 1-Year Low – Should You Sell? - Defense World

Jan 13, 2025
pulisher
Jan 12, 2025

89bio, Inc. (NASDAQ:ETNB) Shares Acquired by Barclays PLC - MarketBeat

Jan 12, 2025
pulisher
Jan 12, 2025

Barclays PLC Acquires 149,479 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World

Jan 12, 2025
pulisher
Jan 11, 2025

Certain Warrant of 89bio, Inc. are subject to a Lock-Up Agreement Ending on 12-JAN-2025. - Marketscreener.com

Jan 11, 2025
pulisher
Jan 11, 2025

89bio (NASDAQ:ETNB) Hits New 52-Week LowHere's Why - MarketBeat

Jan 11, 2025
pulisher
Jan 11, 2025

89bio stock hits 52-week low at $6.42 amid market challenges By Investing.com - Investing.com South Africa

Jan 11, 2025
pulisher
Jan 11, 2025

89bio stock hits 52-week low at $6.42 amid market challenges - Investing.com Australia

Jan 11, 2025
pulisher
Jan 10, 2025

89bio (NASDAQ:ETNB) Stock Price Down 8.2%Here's What Happened - MarketBeat

Jan 10, 2025
pulisher
Jan 09, 2025

Rare Endocrinology and Metabolic Disorders Market Analysis: Emerging Trends and Future Outlook of Hypophosphatasia, Congenital Adrenal Hyperplasia, and Severe Hypertriglyceridemia | DelveInsight - GlobeNewswire Inc.

Jan 09, 2025
pulisher
Jan 08, 2025

Non-Alcoholic Steatohepatitis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Madrigal Pharmac, Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Viking - The Globe and Mail

Jan 08, 2025
pulisher
Jan 07, 2025

Biotech manufacturer plans to cut 120 jobs in Durham - WRAL News

Jan 07, 2025
pulisher
Jan 04, 2025

Brokerages Set 89bio, Inc. (NASDAQ:ETNB) PT at $30.33 - Defense World

Jan 04, 2025
pulisher
Jan 03, 2025

89bio's SWOT analysis: pegozafermin potential drives stock outlook By Investing.com - Investing.com Australia

Jan 03, 2025
pulisher
Jan 03, 2025

89bio (NASDAQ:ETNB) Receives “Overweight” Rating from Cantor Fitzgerald - Defense World

Jan 03, 2025
pulisher
Jan 03, 2025

89bio’s SWOT analysis: pegozafermin potential drives stock outlook By Investing.com - Investing.com Nigeria

Jan 03, 2025
pulisher
Jan 03, 2025

89bio's SWOT analysis: pegozafermin potential drives stock outlook - Investing.com India

Jan 03, 2025
pulisher
Jan 02, 2025

89bio (NASDAQ:ETNB) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat

Jan 02, 2025
pulisher
Jan 01, 2025

89bio, Inc. (NASDAQ:ETNB) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Jan 01, 2025
pulisher
Jan 01, 2025

Head to Head Review: VectivBio (NASDAQ:VECT) versus Tourmaline Bio (NASDAQ:TRML) - Defense World

Jan 01, 2025
pulisher
Dec 31, 2024

89bio (NASDAQ:ETNB) Stock Price Down 3.7%Should You Sell? - MarketBeat

Dec 31, 2024
pulisher
Dec 31, 2024

Jane Street Group LLC Has $1.03 Million Stock Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World

Dec 31, 2024
pulisher
Dec 31, 2024

Jane Street Group LLC Has $1.03 Million Stock Holdings in 89bio, Inc. (NASDAQ:ETNB) - MarketBeat

Dec 31, 2024
pulisher
Dec 30, 2024

89bio, Inc. (NASDAQ:ETNB) Shares Purchased by Geode Capital Management LLC - Defense World

Dec 30, 2024
pulisher
Dec 30, 2024

Geode Capital Management LLC Has $15.36 Million Stock Holdings in 89bio, Inc. (NASDAQ:ETNB) - MarketBeat

Dec 30, 2024
pulisher
Dec 28, 2024

Barclays PLC Boosts Stock Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World

Dec 28, 2024
pulisher
Dec 28, 2024

Barclays PLC Raises Stock Position in 89bio, Inc. (NASDAQ:ETNB) - MarketBeat

Dec 28, 2024
pulisher
Dec 25, 2024

89bio, Inc. (NASDAQ:ETNB) Holdings Reduced by Franklin Resources Inc. - MarketBeat

Dec 25, 2024
pulisher
Dec 24, 2024

89bio Grants Retention RSUs to Key Officers - Defense World

Dec 24, 2024
pulisher
Dec 23, 2024

State Street Corp Acquires 7,184 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World

Dec 23, 2024
pulisher
Dec 22, 2024

89bio (NASDAQ:ETNB) Sets New 52-Week Low – Here’s Why - Defense World

Dec 22, 2024
pulisher
Dec 20, 2024

89bio (NASDAQ:ETNB) Sets New 52-Week LowHere's Why - MarketBeat

Dec 20, 2024
pulisher
Dec 20, 2024

89bio stock hits 52-week low at $6.96 amid market challenges - Investing.com Canada

Dec 20, 2024
$72.93
price down icon 0.75%
$38.89
price up icon 8.29%
$373.68
price up icon 1.47%
$23.79
price up icon 7.65%
biotechnology ONC
$221.90
price up icon 0.97%
$115.49
price down icon 1.44%
Capitalizzazione:     |  Volume (24 ore):